Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins - PubMed (original) (raw)

Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins

C Sample et al. Virology. 1994 Dec.

Abstract

Among the viral proteins expressed in Epstein-Barr virus (EBV)-infected B cells are a family of nuclear proteins known as the Epstein-Barr virus nuclear antigen 3 (EBNA-3) proteins. Two of these, EBNA-3A and EBNA-3C, have an essential but uncharacterized role in the transformation of primary B cells by EBV. EBNA-3C increases expression of two genes likely to be important for B cell growth transformation by EBV, the B cell activation antigen CD21 and the EBV latent membrane protein-1. Since EBNA-3 proteins exhibit DNA-binding capability in crude protein extracts from EBV-transformed cell lines and EBNA-3C contains sequences homologous to a basic leucine zipper motif found in one class of mammalian transcription factors, it is likely that EBNA-3C functions as a transcriptional transactivator. In this paper, we have overexpressed EBNA-3A and -3C in the baculovirus-expression system. To determine whether the ability to bind to DNA is an intrinsic property of the EBNA-3 proteins, we have examined the ability of the recombinant protein to bind to DNA-cellulose. Unlike EBNA-3 proteins in lysates from EBV-transformed cells, neither recombinant protein exhibits significant DNA-binding capability as evidenced by the inability to bind to double-stranded DNA-cellulose. Since this difference in DNA binding could be a result of post-translational modifications, we have examined the phosphorylation status of the EBNA-3 proteins both in EBV-transformed cells and in infected insect cells. EBNA-3A and EBNA-3C were phosphorylated in both cell types. Therefore, if indeed these proteins function as transcriptional transactivators, they may bind to DNA via an indirect mechanism. The recombinant proteins will be invaluable in the further clarification of the role of EBNA-3A and EBNA-3C in EBV-induced immortalization of B cells.

PubMed Disclaimer

Cited by

Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.
Bain M, Watson RJ, Farrell PJ, Allday MJ. Bain M, et al. J Virol. 1996 Apr;70(4):2481-9. doi: 10.1128/JVI.70.4.2481-2489.1996. J Virol. 1996. PMID: 8642676 Free PMC article.
Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression.
Paschos K, Bazot Q, Ho G, Parker GA, Lees J, Barton G, Allday MJ. Paschos K, et al. Nucleic Acids Res. 2017 Mar 17;45(5):2368-2383. doi: 10.1093/nar/gkw1167. Nucleic Acids Res. 2017. PMID: 27903901 Free PMC article.
Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
Radkov SA, Bain M, Farrell PJ, West M, Rowe M, Allday MJ. Radkov SA, et al. J Virol. 1997 Nov;71(11):8552-62. doi: 10.1128/JVI.71.11.8552-8562.1997. J Virol. 1997. PMID: 9343213 Free PMC article.
A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa.
Zhao B, Marshall DR, Sample CE. Zhao B, et al. J Virol. 1996 Jul;70(7):4228-36. doi: 10.1128/JVI.70.7.4228-4236.1996. J Virol. 1996. PMID: 8676443 Free PMC article.
Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.
Kuppers DA, Lan K, Knight JS, Robertson ES. Kuppers DA, et al. J Virol. 2005 Aug;79(15):9714-24. doi: 10.1128/JVI.79.15.9714-9724.2005. J Virol. 2005. PMID: 16014933 Free PMC article.

Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins - PubMed (original) (raw)